Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treg cells-the next frontier of cell therapy.

Literature DB >> 30309932

T_reg cells-the next frontier of cell therapy.

Jeffrey A Bluestone^1,2, Qizhi Tang³.

Abstract

Mesh：

Year: 2018 PMID： 30309932 DOI： 10.1126/science.aau2688

Source DB: PubMed Journal: Science ISSN： 0036-8075 Impact factor: 47.728

Keyword Cloud
Cited

× No keyword cloud information.

54 in total

Review 1. Tolerogenic vaccines: Targeting the antigenic and cytokine niches of FOXP3⁺ regulatory T cells.

Authors: Mark D Mannie; Kayla B DeOca; Alexander G Bastian; Cody D Moorman
Journal: Cell Immunol Date: 2020-07-15 Impact factor: 4.868

Review 2. Type 1 diabetes pathogenesis and the role of inhibitory receptors in islet tolerance.

Authors: Tijana Martinov; Brian T Fife
Journal: Ann N Y Acad Sci Date: 2019-04-26 Impact factor: 5.691

3. Characterization of regulatory T cell expansion for manufacturing cellular immunotherapies.

Authors: David A McBride; Matthew D Kerr; Shinya L Wai; Yvonne Y Yee; Dora A Ogbonna; Nisarg J Shah
Journal: Biomater Sci Date: 2020-05-22 Impact factor: 6.843

4. Anti-inflammatory Roles of Glucocorticoids Are Mediated by Foxp3⁺ Regulatory T Cells via a miR-342-Dependent Mechanism.

Authors: Dongkyun Kim; Quang Tam Nguyen; Juyeun Lee; Sung Hwan Lee; Allison Janocha; Sohee Kim; Hongnga T Le; Nina Dvorina; Kelly Weiss; Mark J Cameron; Kewal Asosingh; Serpil C Erzurum; William M Baldwin; Ju-Seog Lee; Booki Min
Journal: Immunity Date: 2020-07-23 Impact factor: 31.745

T_reg cells-the next frontier of cell therapy.

Review 1. Tolerogenic vaccines: Targeting the antigenic and cytokine niches of FOXP3⁺ regulatory T cells.

Review 2. Type 1 diabetes pathogenesis and the role of inhibitory receptors in islet tolerance.

3. Characterization of regulatory T cell expansion for manufacturing cellular immunotherapies.

4. Anti-inflammatory Roles of Glucocorticoids Are Mediated by Foxp3⁺ Regulatory T Cells via a miR-342-Dependent Mechanism.

Review 5. Therapeutic use of regulatory T cells for graft-versus-host disease.

6. Regulatory T cells suppress excessive lipid accumulation in alcoholic liver disease.

Review 7. T_reg cell-based therapies: challenges and perspectives.

Review 8. Tolerance in the Age of Immunotherapy.

Review 9. Insights into the biology and therapeutic implications of TNF and regulatory T cells.

10. Hybrid lipids, peptides, and lymphocytes: new era in type 1 diabetes research.

Treg cells-the next frontier of cell therapy.

Review 1. Tolerogenic vaccines: Targeting the antigenic and cytokine niches of FOXP3+ regulatory T cells.

Review 2. Type 1 diabetes pathogenesis and the role of inhibitory receptors in islet tolerance.

3. Characterization of regulatory T cell expansion for manufacturing cellular immunotherapies.

4. Anti-inflammatory Roles of Glucocorticoids Are Mediated by Foxp3+ Regulatory T Cells via a miR-342-Dependent Mechanism.

Review 5. Therapeutic use of regulatory T cells for graft-versus-host disease.

6. Regulatory T cells suppress excessive lipid accumulation in alcoholic liver disease.

Review 7. Treg cell-based therapies: challenges and perspectives.

Review 8. Tolerance in the Age of Immunotherapy.

Review 9. Insights into the biology and therapeutic implications of TNF and regulatory T cells.

10. Hybrid lipids, peptides, and lymphocytes: new era in type 1 diabetes research.

T_reg cells-the next frontier of cell therapy.

Review 1. Tolerogenic vaccines: Targeting the antigenic and cytokine niches of FOXP3⁺ regulatory T cells.

4. Anti-inflammatory Roles of Glucocorticoids Are Mediated by Foxp3⁺ Regulatory T Cells via a miR-342-Dependent Mechanism.

Review 7. T_reg cell-based therapies: challenges and perspectives.